Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.bbadis.2011.01.003PMID 21216282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

  2010cited by this paper
• Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.

  2010cited by this paper
• Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease

  2010cited by this paper
• Effect of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial

  2009cited by this paper
• Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data

  2009cited by this paper
• Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).

  2009cited by this paper
• Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis[S]

  2009cited by this paper
• Genetic differences in oxidative stress and inflammatory responses to diet‐induced obesity do not alter liver fibrosis in mice

  2009cited by this paper
• Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice

  2009cited by this paper
• Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial.

  2008cited by this paper
• Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome

  2008cited by this paper
• A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.

  2008cited by this paper
• The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.

  2008cited by this paper
• Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease

  2008cited by this paper
• The epidemiology of nonalcoholic fatty liver disease: a global perspective.

  2008cited by this paper
• Animal models of NASH: Getting both pathology and metabolic context right

  2008cited by this paper
• Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.

  2008cited by this paper
• Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

  2008cited by this paper
• VAT fat is bad for the liver, SAT fat is not!

  2008cited by this paper
• Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1).

  2007cited by this paper
• Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet

  2007cited by this paper
• A lipidomic analysis of nonalcoholic fatty liver disease

  2007cited by this paper
• Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects

  2007cited by this paper
• Lipid‐induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet

  2007cited by this paper
• Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor γ (PPARγ) and PPARγcoactivator-1 (PGC1)

  2007cited by this paper
• Identification of a Domain within Peroxisome Proliferator-Activated Receptor γ Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in Adipocytes

  2007cited by this paper
• Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

  2007cited by this paper
• Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis.

  2006cited by this paper
• Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.

  2006cited by this paper
• Autocrine Tumor Necrosis Factor Alpha Links Endoplasmic Reticulum Stress to the Membrane Death Receptor Pathway through IRE1α-Mediated NF-κB Activation and Down-Regulation of TRAF2 Expression

  2006cited by this paper
• Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis.

  2006cited by this paper
• Heme oxygenase-1 as a potential therapeutic target for hepatoprotection.

  2006cited by this paper
• An Improved, Single Step Standardized Method of Lipid Extraction from Human Skeletal Muscle Tissue

  2006cited by this paper
• Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology

  2006cited by this paper
• Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

  2006cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Steatohepatitis induced by intragastric overfeeding in mice

  2005cited by this paper
• Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients.

  2005cited by this paper
• Molecular mediators of hepatic steatosis and liver injury.

  2004cited by this paper
• Effects of dietary fatty acids on insulin sensitivity and secretion

  2004cited by this paper
• Splanchnic lipolysis in human obesity.

  2004cited by this paper
• Model of nonalcoholic steatohepatitis.

  2004cited by this paper
• Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass*

  2003cited by this paper
• Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis

  2003cited by this paper
• Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

  2003cited by this paper
• Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver.

  2001cited by this paper
• Up-Regulation of Peroxisome Proliferator-Activated Receptors (PPAR-α) and PPAR-γ Messenger Ribonucleic Acid Expression in the Liver in Murine Obesity: Troglitazone Induces Expression of PPAR-γ-Responsive Adipose Tissue-Specific Genes in the Liver of Obese Diabetic Mice* * This work was supported by

  2000cited by this paper
• Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.

  2000cited by this paper
• Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes.

  1998cited by this paper
• Hepatic steatosis: Innocent bystander or guilty party?

  1998cited by this paper
• Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

  1998cited by this paper
• Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis.

  1997cited by this paper
• Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.

  1994cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper

• Hepatocyte-specific angiotensinogen deficiency inhibits Western diet-induced liver steatosis with suppression of cell division in mice

  2025cites this paper
• Bridging lipid metabolism and mitochondrial genome maintenance

  2024cites this paper
• O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36.

  2024cites this paper
• Natural polysaccharides protect against diet-induced obesity by improving lipid metabolism and regulating the immune system.

  2023cites this paper
• Longitudinal study of cirrhosis development in STAM™ and CCl4 mouse models using FTIR spectral imaging.

  2023cites this paper
• MicroRNA-200c coordinates HNF1 homeobox B and apolipoprotein O functions to modulate lipid homeostasis in alcoholic fatty liver disease

  2022cites this paper
• Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver

  2022cites this paper
• The physiology of experimental overfeeding in animals

  2022cites this paper
• The ameliorative effect of probiotics on diet-induced lipid metabolism disorders: A review

  2022cites this paper
• Loss of Stearoyl-CoA Desaturase 1 leads to cardiac dysfunction and lipotoxicity.

  2021cites this paper
• Protective and ameliorating effects of probiotics against diet-induced obesity: A review.

  2021cites this paper
• High Glucose and Liver Fatty Acid Binding Protein Gene Ablation Differentially Impact Whole Body and Liver Phenotype in High-Fat Pair-Fed Mice.

  2020cites this paper
• High Glucose Aggravates Cholesterol Accumulation in Glomerular Endothelial Cells Through the LXRs/LncRNAOR13C9/ABCA1 Regulatory Network

  2020cites this paper
• In Search of Zonation Markers to Identify Liver Functional Disorders

  2020cites this paper
• High glucose aggravates lipid deposition in glomerular endothelial cells by LXRs/LncRNAOR13C9/ABCA1 pathway

  2020cites this paper
• Chinese olive (Canarium album L.) fruit regulates glucose utilization by activating AMP‐activated protein kinase

  2020cites this paper
• Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

  2020cites this paper
• Polysaccharides derived from natural sources regulate triglyceride and cholesterol metabolism: a review of the mechanisms.

  2019cites this paper
• Tyrosine Kinase Inhibitors in the Treatment of Hepatocellular Carcinoma

  2019cites this paper
• Mouse Models of Hepatocellular Carcinoma

  2019cites this paper
• Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease.

  2019cites this paper
• Sterol Carrier Protein-2/Sterol Carrier Protein-x/Fatty Acid Binding Protein-1 Ablation Impacts Response of Brain Endocannabinoid to High-Fat Diet.

  2019cites this paper
• Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice

  2019cites this paper
• Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System.

  2018cites this paper
• Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice

  2018cites this paper
• Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease.

  2018cites this paper
• Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway

  2018cites this paper
• Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat.

  2018cites this paper
• Metabolic adaptations in models of fatty liver disease Hijmans

  2017cites this paper
• Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaem

  2017cites this paper
• Sulfated polysaccharides from Enteromorpha prolifera suppress SREBP-2 and HMG-CoA reductase expression and attenuate non-alcoholic fatty liver disease induced by a high-fat diet.

  2017cites this paper
• Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis

  2017cites this paper
• Long-term exposure to a butter-rich diet induces mild-to-moderate steatosis in Chang liver cells and Swiss albino mice models

  2017cites this paper
• Zonation of hepatic fat accumulation: insights from mathematical modelling of nutrient gradients and fatty acid uptake

  2017cites this paper
• Metalloproteinases in liver fibrosis: current insights

  2017cites this paper
• Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet[S]

  2017cites this paper
• Fibroblast Growth Factor 21—Metabolic Role in Mice and Men

  2017cites this paper
• Metabolic adaptations in models of fatty liver disease: Of mice and math

  2017cites this paper
• Hepatocyte β‐Klotho regulates lipid homeostasis but not body weight in mice

  2016cites this paper
• Insulin Protects Hepatic Lipotoxicity by Regulating ER Stress through the PI3K/Akt/p53 Involved Pathway Independently of Autophagy Inhibition

  2016cites this paper
• Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease*

  2016cites this paper
• Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis

  2015cites this paper
• Molecular insights into the mechanisms of liver-associated diseases in early-lactating dairy cows: hypothetical role of endoplasmic reticulum stress.

  2015cites this paper
• Disparate metabolic response to fructose feeding between different mouse strains

  2015cites this paper
• Beneficial Effects of Red Yeast Rice on High-Fat Diet-Induced Obesity, Hyperlipidemia, and Fatty Liver in Mice

  2015cites this paper
• Brown Alga Ecklonia cava polyphenol extract ameliorates hepatic lipogenesis, oxidative stress, and inflammation by activation of AMPK and SIRT1 in high-fat diet-induced obese mice.

  2015cites this paper
• Heme-regulated eIF2α kinase plays a crucial role in protecting erythroid cells against Pb-induced hemolytic stress.

  2015cites this paper
• New insights into the pathophysiology of dyslipidemia in type 2 diabetes.

  2015cites this paper
• Youngia denticulata attenuates diet-induced obesity-related metabolic dysfunctions by activating AMP-activated protein kinase and regulating lipid metabolism

  2015cites this paper
• LIPOPOLYSACCHARIDE (LPS) AND MURAMYL DIPEPTIDE (MDP) INDUCED CHRONIC LIVER INJURY IN HIGH FAT DIET FED RAT–A POSSIBLE MODEL FOR NON ALCOHOLIC FATTY LIVER DISEASE

  2015cites this paper
• DEVELOPMENT OF MICROVESICULAR AND MACROVESICULAR STEATOSIS IS ASSOCIATED WITH DISTINCT INFLAMMATORY EVENTS IN LIVERS: A TIME-COURSE STUDY OF CHOLESTEROL-INDUCED NASH

  2015cites this paper
• DNA microarray analysis of genes differentially expressed in adipocyte differentiation

  2014cites this paper
• Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.

  2014cites this paper
• Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPARγ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease

  2014cites this paper
• Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis

  2014cites this paper
• Relationship of SREBP-2 rs2228314 G>C Polymorphism with Nonalcoholic Fatty Liver Disease in a Han Chinese Population

  2014cites this paper
• A high-protein diet is anti-steatotic and has no pro-inflammatory side effects in dyslipidaemic APOE2 knock-in mice

  2014cites this paper
• The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target

  2014cites this paper
• High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice

  2013cites this paper
• The role of estrogen in hypothalamic regulation of hypothalamus-pituitary-adrenal axis activity , energy homeostasis and bone metabolism

  2013influential citation
• High-fat diet stimulates hepatic cystathionine β-synthase and cystathionine γ-lyase expression.

  2013cites this paper
• The role of estrogen in hypothalamic regulation of hypothalamus-pituitary-adrenal axis activity, energy homeostasis and bone metabolism

  2013cites this paper
• Адипонектин: благоприятное воздействие на метаболические и сердечно-сосудистые нарушения

  2013cites this paper
• Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs.

  2013cites this paper
• Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding.

  2013cites this paper
• Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.

  2013cites this paper
• Animal Models of Non-alcoholic Fatty Liver Disease : from Genetics to Nutrition

  2013cites this paper
• Metabolically Protective Cytokines Adiponectin and Fibroblast Growth Factor-21 Are Increased by Acute Overfeeding in Healthy Humans

  2013cites this paper
• Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance

  2013cites this paper
• Ethnic Differences in the Link Between Insulin Resistance and Elevated ALT

  2013cites this paper
• Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress

  2013cites this paper
• Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis.

  2013cites this paper
• Changes in the hepatic mitochondrial and membrane proteome in mice fed a non-alcoholic steatohepatitis inducing diet.

  2013cites this paper
• Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation.

  2013cites this paper
• Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.

  2013cites this paper
• Fibroblast growth factor 21 is induced by endoplasmic reticulum stress.

  2013cites this paper
• Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll‐like receptor activation

  2012cites this paper
• Non-alcoholic steatohepatitis: what can we learn from animal models?

  2012cites this paper
• Role of cardiac FoxO1 in conditions of insulin resistance, nutrient excess, and diabetes

  2012cites this paper
• Folic acid supplementation attenuates high fat diet induced hepatic oxidative stress via regulation of NADPH oxidase.

  2012cites this paper
• ESTUDIO MORFOMÉTRICO DEL HÍGADO DE RATAS WISTAR EN UN MODELO EXPERIMENTAL DE HIPERLIPIDEMIA.

  2012cites this paper
• Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids.

  2012cites this paper
• Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.

  2012cites this paper
• Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet

  2012cites this paper
• Ω3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet

  2012cites this paper
• Inhibition of Intestinal Bile Acid Transporter Slc10a2 Improves Triglyceride Metabolism and Normalizes Elevated Plasma Glucose Levels in Mice

  2012cites this paper
• chronically elevated glucocorticoids development of fatty liver disease that occurs with Consumption of a high-fat diet rapidly exacerbates the

  2012cites this paper
• Short Communication Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-a

  2012cites this paper
• FABP4 Dynamics in Obesity: Discrepancies in Adipose Tissue and Liver Expression Regarding Circulating Plasma Levels

  2012cites this paper
• Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis.

  2011cites this paper
• Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-α

  2011cites this paper
• Blend infusion of some aromatic plants ameliorates carbon tetrachloride-induced hepatic damage in rats by inhibition of oxidative stress

  2011cites this paper